Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS, M.C.P.S
Diabetologist
M.B.B.S, F.C.P.S. (Medicine) , MD (USA)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Diabetologist
M.B.B.S, M.R.C.P, PG Dip.Diabetes (UK), MD-Diabetes & Endocrine
Diabetologist
M.B.B.S, M.R.C.P, PG Dip.Diabetes (UK), MD-Diabetes & Endocrine
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
General Physician
M.B.B.S , M.C.P.S (Family Medicine)
Diabetologist
M.B.B.S, M.Phil.
Internal Medicine Specialist
M.B.B.S., F.C.P.S., M.R.C.P, F.R.C.P.
Internal Medicine Specialist
MBBS, MD, MCPS
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures